Historical record - last NADAC effective date: 9/20/2023
Product Information
AMLODIPINE-ATORVAST 5-40 MG is a generic product labeled by Dr. Reddy's Laboratories Inc., priced at $1.7150 per EA under NDC 43598031630. Its NADAC has been published 503 times since May 14, 2014.
FDA first approved this application on Mar 7, 2014. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5; 40 mg/1; mg/1
Manufacturer
Dr. Reddy's Laboratories Inc.NDC
43598031630
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/20/2023
Active Ingredients
AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATEApproval Type
Generic (ANDA)
FDA Application
ANDA203874FDA Approved
3/7/2014
TE Code
AB
On Market Since
3/17/2014
Pharmacological Classes
Price Statistics
The NADAC for AMLODIPINE-ATORVAST 5-40 MG has been published 503 times since May 14, 2014, and over the history we have for it it has declined 74.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.7150 per EA |
|---|---|
| All-time high | $7.1119 (Aug 13, 2014) |
| All-time low | $1.5035 (Dec 21, 2022) |
| Median price | $4.3710 |
| Average price | $4.3278 |
| Largest weekly change | +58.2% (Feb 22, 2023) |
| Weeks tracked | 503 |
| Tracking since | May 14, 2014 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
0.0%
5Y
-48.1%
All
-74.1%
Last surveyed Dec 27, 2023 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Dr. Reddy's Laboratories Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Amlodipine besylate and Atorvastatin calcium market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Dihydropyridine Calcium Channel Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of AMLODIPINE-ATORVAST 5-40 MG?
The current National Average Drug Acquisition Cost (NADAC) for AMLODIPINE-ATORVAST 5-40 MG, manufactured by Dr. Reddy's Laboratories Inc., is $1.7150 per EA (NDC 43598031630), effective Dec 27, 2023.
How has the price of AMLODIPINE-ATORVAST 5-40 MG changed over time?
Over the history we have for it, the NADAC for AMLODIPINE-ATORVAST 5-40 MG has declined 74.1%. It has been tracked across 503 weekly CMS publications since May 14, 2014.
What are the highest and lowest recorded NADAC prices for AMLODIPINE-ATORVAST 5-40 MG?
Since May 14, 2014, the NADAC for AMLODIPINE-ATORVAST 5-40 MG has ranged from a low of $1.5035 (Dec 21, 2022) to a high of $7.1119 (Aug 13, 2014), with a median of $4.3710 per EA.
Are there cheaper alternatives to AMLODIPINE-ATORVAST 5-40 MG?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as AMLODIPINE-ATORVAST 5-40 MG in a comparable dosage form, but none are currently priced below it.
Who manufactures AMLODIPINE-ATORVAST 5-40 MG?
AMLODIPINE-ATORVAST 5-40 MG (NDC 43598031630) is labeled by Dr. Reddy's Laboratories Inc., and CMS classifies it as a generic product.